A Bispecific EpCAM/CD133-targeted Toxin Is Effective Against Carcinoma

Targeted Oncology - France
doi 10.1007/s11523-013-0290-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeted Silencing of Anthrax Toxin Receptors Protects Against Anthrax Toxins

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

Cd133/Epcam Cancer Stem Cell Markers of Tumour Stage in Colorectal Cancer Cells

Journal of Tissue Science & Engineering
2015English

Hepatocellular Carcinoma: Is Surveillance Cost Effective?

Gut
Gastroenterology
2001English

A Third-Generation Herpesvirus Is Effective Against Gastroesophageal Cancer

Journal of Surgical Research
Surgery
2010English

High Expression of EpCAM and Sox2 Is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma

Scientific Reports
Multidisciplinary
2018English

Targeted Inhibition of Superoxide Dismutase 1 Is Effective in NSCLC

Cancer Discovery
Oncology
2013English

Evaluation of Cytotoxicity of Bispecific Antibody Against Mesothelioma

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

A Reprofiled Drug, Auranofin, Is Effective Against Metronidazole-Resistant Giardia Lamblia

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

Genetic Alteration of a Bispecific Ligand-Directed Toxin Targeting Human CD19 and CD22 Receptors Resulting in Improved Efficacy Against Systemic B Cell Malignancy

Leukemia Research
Cancer ResearchOncologyHematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy